Black Rock Inc. Acasti Pharma Inc. Transaction History

Black Rock Inc.

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 13, 2023	BUY	$0.34 - $3.78 $21 - $234	62 New	62 $0

Ticker ACST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,610,100
Market Cap $145M
Description
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.